Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.57
Delayed Data
As of 4:01pm ET
 +0.0303 / +5.61%
Today’s Change
0.50
Today|||52-Week Range
0.96
-18.57%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.54
Today’s open0.54
Day’s range0.54 - 0.58
Volume279,273
Average volume (3 months)599,203
Market cap$96.7M
Dividend yield--
Data as of 4:01pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...-0.08-3.03%
OGENOragenics Inc+0.58+22.14%
PULMPulmatrix Inc-0.19-2.79%
MNOVMediciNova Inc-0.02-0.53%
Data as of 4:03pm ET, 08/03/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer &
Secretary
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts